Revvity EBITDA Margin 2012-2025 | RVTY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Revvity (RVTY) over the last 10 years. The current EBITDA margin for Revvity as of December 31, 2025 is .
| Revvity EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $2.81B | $0.78B | 27.59% |
| 2025-06-30 | $2.80B | $0.80B | 28.52% |
| 2025-03-31 | $2.77B | $0.80B | 28.81% |
| 2024-12-31 | $2.76B | $0.78B | 28.35% |
| 2024-09-30 | $2.72B | $0.74B | 27.19% |
| 2024-06-30 | $2.71B | $0.71B | 26.28% |
| 2024-03-31 | $2.73B | $0.71B | 25.90% |
| 2023-12-31 | $2.75B | $0.74B | 26.86% |
| 2023-09-30 | $2.80B | $0.80B | 28.54% |
| 2023-06-30 | $2.84B | $0.85B | 29.89% |
| 2023-03-31 | $3.02B | $1.02B | 33.70% |
| 2022-12-31 | $3.31B | $1.22B | 36.90% |
| 2022-09-30 | $3.00B | $1.38B | 45.92% |
| 2022-06-30 | $3.15B | $1.41B | 44.67% |
| 2022-03-31 | $3.48B | $1.46B | 41.87% |
| 2021-12-31 | $3.83B | $1.61B | 42.07% |
| 2021-09-30 | $3.63B | $1.63B | 44.88% |
| 2021-06-30 | $3.74B | $1.68B | 45.09% |
| 2021-03-31 | $3.32B | $1.51B | 45.47% |
| 2020-12-31 | $2.66B | $1.07B | 40.33% |
| 2020-09-30 | $3.23B | $0.86B | 26.60% |
| 2020-06-30 | $2.98B | $0.69B | 23.15% |
| 2020-03-31 | $2.89B | $0.60B | 20.92% |
| 2019-12-31 | $2.88B | $0.60B | 20.87% |
| 2019-09-30 | $2.84B | $0.56B | 19.82% |
| 2019-06-30 | $2.80B | $0.55B | 19.52% |
| 2019-03-31 | $2.78B | $0.54B | 19.34% |
| 2018-12-31 | $2.78B | $0.53B | 18.98% |
| 2018-09-30 | $2.66B | $0.49B | 18.33% |
| 2018-06-30 | $2.54B | $0.47B | 18.36% |
| 2018-03-31 | $2.39B | $0.43B | 17.89% |
| 2017-12-31 | $2.26B | $0.41B | 18.17% |
| 2017-09-30 | $2.18B | $0.40B | 18.42% |
| 2017-06-30 | $2.14B | $0.40B | 18.58% |
| 2017-03-31 | $2.13B | $0.39B | 18.21% |
| 2016-12-31 | $2.12B | $0.40B | 18.77% |
| 2016-09-30 | $2.00B | $0.35B | 17.56% |
| 2016-06-30 | $2.05B | $0.35B | 17.29% |
| 2016-03-31 | $2.08B | $0.36B | 17.34% |
| 2015-12-31 | $2.11B | $0.37B | 17.34% |
| 2015-09-30 | $2.10B | $0.30B | 14.51% |
| 2015-06-30 | $2.07B | $0.29B | 13.89% |
| 2015-03-31 | $2.07B | $0.29B | 13.99% |
| 2014-12-31 | $2.07B | $0.28B | 13.48% |
| 2014-09-30 | $2.22B | $0.40B | 17.90% |
| 2014-06-30 | $2.20B | $0.40B | 18.24% |
| 2014-03-31 | $2.18B | $0.38B | 17.18% |
| 2013-12-31 | $2.16B | $0.36B | 16.74% |
| 2013-09-30 | $2.13B | $0.24B | 11.12% |
| 2013-06-30 | $2.12B | $0.22B | 10.38% |
| 2013-03-31 | $2.10B | $0.23B | 10.95% |
| 2012-12-31 | $2.11B | $0.24B | 11.25% |
| 2012-09-30 | $2.08B | $0.25B | 11.82% |
| 2012-06-30 | $2.03B | $0.24B | 11.65% |
| 2012-03-31 | $1.98B | $0.22B | 11.10% |
| 2011-12-31 | $1.92B | $0.21B | 11.05% |
| 2011-09-30 | $1.85B | $0.27B | 14.84% |
| 2011-06-30 | $1.81B | $0.27B | 15.12% |
| 2011-03-31 | $1.76B | $0.26B | 15.04% |
| 2010-12-31 | $1.70B | $0.25B | 14.63% |
| 2010-09-30 | $1.54B | $0.23B | 14.85% |
| 2010-06-30 | $1.49B | $0.20B | 13.33% |
| 2010-03-31 | $1.51B | $0.20B | 13.45% |
| 2009-12-31 | $1.55B | $0.20B | 12.90% |
| 2009-09-30 | $1.47B | $0.18B | 12.47% |
| 2009-06-30 | $1.57B | $0.21B | 13.58% |
| 2009-03-31 | $1.64B | $0.22B | 13.39% |
| 2008-12-31 | $1.66B | $0.23B | 13.61% |
| 2008-09-30 | $1.90B | $0.26B | 13.55% |
| 2008-06-30 | $1.85B | $0.26B | 13.82% |
| 2008-03-31 | $1.79B | $0.26B | 14.40% |
| 2007-12-31 | $1.73B | $0.25B | 14.23% |
| 2007-09-30 | $1.63B | $0.24B | 14.63% |
| 2007-06-30 | $1.59B | $0.23B | 14.38% |
| 2007-03-31 | $1.53B | $0.21B | 13.97% |
| 2006-12-31 | $1.48B | $0.22B | 14.56% |
| 2006-09-30 | $1.51B | $0.27B | 17.72% |
| 2006-06-30 | $1.48B | $0.28B | 18.65% |
| 2006-03-31 | $1.47B | $0.27B | 18.01% |
| 2005-12-31 | $1.47B | $0.27B | 18.05% |
| 2005-09-30 | $1.37B | $0.21B | 15.12% |
| 2005-06-30 | $1.35B | $0.19B | 14.06% |
| 2005-03-31 | $1.40B | $0.21B | 14.98% |
| 2004-12-31 | $1.43B | $0.21B | 14.90% |
| 2004-09-30 | $1.39B | $0.21B | 15.38% |
| 2004-06-30 | $1.42B | $0.22B | 15.83% |
| 2004-03-31 | $1.38B | $0.22B | 15.66% |
| 2003-12-31 | $1.34B | $0.21B | 15.33% |
| 2003-09-30 | $1.51B | $0.18B | 12.08% |
| 2003-06-30 | $1.51B | $0.17B | 11.02% |
| 2003-03-31 | $1.51B | $0.15B | 10.18% |
| 2002-12-31 | $1.50B | $0.12B | 8.19% |
| 2002-09-30 | $1.62B | $0.13B | 8.11% |
| 2002-06-30 | $1.60B | $0.17B | 10.89% |
| 2002-03-31 | $1.54B | $0.19B | 12.50% |
| 2001-12-31 | $1.53B | $0.24B | 15.67% |
| 2001-09-30 | $1.47B | $0.29B | 19.51% |
| 2001-06-30 | $1.46B | $0.23B | 15.50% |
| 2001-03-31 | $1.51B | $0.23B | 15.46% |
| 2000-12-31 | $1.57B | $0.23B | 14.68% |
| 2000-09-30 | $1.54B | $0.31B | 20.08% |
| 2000-06-30 | $1.59B | $0.33B | 20.79% |
| 2000-03-31 | $1.52B | $0.30B | 19.59% |
| 1999-12-31 | $1.36B | $0.17B | 12.19% |
| 1999-09-30 | $1.17B | $-0.07B | -5.56% |
| 1999-06-30 | $0.97B | $-0.23B | -23.54% |
| 1999-03-31 | $0.88B | $-0.38B | -43.39% |
| 1998-12-31 | $0.99B | $-0.27B | -27.55% |
| 1998-09-30 | $1.14B | $-0.16B | -14.16% |
| 1998-06-30 | $1.31B | $-0.01B | -0.76% |
| 1998-03-31 | $1.47B | $0.14B | 9.25% |
| 1997-12-31 | $1.46B | $0.13B | 9.03% |
| 1997-09-30 | $1.44B | $0.12B | 8.38% |
| 1997-06-30 | $1.44B | $0.12B | 8.61% |
| 1997-03-31 | $1.43B | $0.13B | 8.89% |
| 1996-12-31 | $1.43B | $0.13B | 9.03% |
| 1996-09-30 | $1.44B | $0.12B | 8.50% |
| 1996-06-30 | $1.44B | $0.11B | 7.35% |
| 1996-03-31 | $1.43B | $0.10B | 6.65% |
| 1995-12-31 | $1.42B | $0.08B | 5.78% |
| 1995-09-30 | $1.38B | $-0.62B | -45.08% |
| 1995-06-30 | $1.36B | $-0.63B | -46.20% |
| 1995-03-31 | $1.66B | $-0.62B | -37.39% |
| 1994-12-31 | $2.00B | $-0.62B | -30.77% |
| 1994-09-30 | $2.30B | $0.10B | 4.26% |
| 1994-06-30 | $2.71B | $0.11B | 3.99% |
| 1994-03-31 | $2.73B | $0.11B | 4.15% |
| 1993-12-31 | $2.70B | $0.12B | 4.45% |
| 1993-09-30 | $2.75B | $0.12B | 4.19% |
| 1993-06-30 | $2.75B | $0.12B | 4.44% |
| 1993-03-31 | $2.78B | $0.12B | 4.46% |
| 1992-12-31 | $2.79B | $0.12B | 4.37% |
| 1992-09-30 | $2.74B | $0.13B | 4.67% |
| 1992-06-30 | $2.74B | $0.13B | 4.71% |
| 1992-03-31 | $2.71B | $0.13B | 4.65% |
| 1991-12-31 | $2.69B | $0.12B | 4.61% |
| 1991-09-30 | $2.66B | $0.12B | 4.51% |
| 1991-06-30 | $2.60B | $0.11B | 4.38% |
| 1991-03-31 | $2.55B | $0.11B | 4.31% |
| 1990-12-31 | $2.47B | $0.11B | 4.37% |
| 1990-09-30 | $2.28B | $0.11B | 4.65% |
| 1990-06-30 | $2.02B | $0.10B | 4.95% |
| 1990-03-31 | $1.82B | $0.10B | 5.49% |
| 1989-12-31 | $1.65B | $0.10B | 6.00% |
| 1989-09-30 | $1.64B | $0.10B | 6.22% |
| 1989-06-30 | $1.56B | $0.10B | 6.49% |
| 1989-03-31 | $1.48B | $0.10B | 6.71% |
| 1988-12-31 | $1.41B | $0.10B | 6.98% |
| 1988-09-30 | $1.34B | $0.09B | 7.03% |
| 1988-06-30 | $1.32B | $0.09B | 7.15% |
| 1988-03-31 | $1.29B | $0.09B | 6.83% |
| 1987-12-31 | $1.27B | $0.08B | 6.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.887B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.156B | 27.25 |
| HCA Healthcare (HCA) | United States | $120.821B | 19.12 |
| CVS Health (CVS) | United States | $99.843B | 11.63 |
| Elevance Health (ELV) | United States | $76.540B | 11.49 |
| Cencora (COR) | United States | $70.193B | 22.08 |
| Natera (NTRA) | United States | $28.526B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.430B | 17.86 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.163B | 6.77 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.306B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.104B | 12.72 |
| Medpace Holdings (MEDP) | United States | $12.148B | 27.98 |
| CochLear (CHEOY) | Australia | $9.243B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.941B | 15.29 |
| ICON (ICLR) | Ireland | $7.510B | 7.45 |
| Sonic Healthcare (SKHHY) | Australia | $7.449B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.008B | 41.78 |
| HealthEquity (HQY) | United States | $6.312B | 23.60 |
| Avantor (AVTR) | United States | $6.275B | 10.11 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| PACS (PACS) | United States | $5.922B | 36.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.818B | 0.00 |
| Sotera Health (SHC) | United States | $4.864B | 23.45 |
| Alignment Healthcare (ALHC) | United States | $4.040B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.017B | 18.83 |
| GeneDx Holdings (WGS) | United States | $2.606B | 45.76 |
| Establishment Labs Holdings (ESTA) | United States | $2.168B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.000B | 25.77 |
| Organon (OGN) | United States | $1.921B | 2.15 |
| Pediatrix Medical (MD) | United States | $1.848B | 11.04 |
| Progyny (PGNY) | United States | $1.784B | 35.07 |
| Ardent Health (ARDT) | United States | $1.375B | 4.49 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.010B | 16.50 |
| Teladoc Health (TDOC) | United States | $0.825B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Nutex Health (NUTX) | United States | $0.705B | 5.39 |
| Omada Health (OMDA) | United States | $0.655B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.641B | 0.00 |
| Embecta (EMBC) | United States | $0.602B | 3.36 |
| Enhabit (EHAB) | United States | $0.565B | 25.36 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.558B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.478B | 8.79 |
| CryoPort (CYRX) | United States | $0.418B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.367B | 5.90 |
| So-Young (SY) | China | $0.328B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.247B | 0.00 |
| Agilon Health (AGL) | United States | $0.150B | 0.00 |
| LifeMD (LFMD) | United States | $0.134B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.073B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.018B | 5.62 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |